AU2002231811A1 - Use of flumazenil to produce a medicament for the treatment of cocaine dependency - Google Patents
Use of flumazenil to produce a medicament for the treatment of cocaine dependencyInfo
- Publication number
- AU2002231811A1 AU2002231811A1 AU2002231811A AU2002231811A AU2002231811A1 AU 2002231811 A1 AU2002231811 A1 AU 2002231811A1 AU 2002231811 A AU2002231811 A AU 2002231811A AU 2002231811 A AU2002231811 A AU 2002231811A AU 2002231811 A1 AU2002231811 A1 AU 2002231811A1
- Authority
- AU
- Australia
- Prior art keywords
- flumazenil
- medicament
- produce
- treatment
- cocaine dependency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OFBIFZUFASYYRE-UHFFFAOYSA-N Flumazenil Chemical compound C1N(C)C(=O)C2=CC(F)=CC=C2N2C=NC(C(=O)OCC)=C21 OFBIFZUFASYYRE-UHFFFAOYSA-N 0.000 title 1
- 229960004381 Flumazenil Drugs 0.000 title 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 title 1
- 229960003920 cocaine Drugs 0.000 title 1
- ZPUCINDJVBIVPJ-BARDWOONSA-N cocaine Natural products O([C@@H]1C[C@H]2CC[C@H](N2C)[C@@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-BARDWOONSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2006200922A AU2006200922A1 (en) | 2001-02-15 | 2006-03-03 | Use of flumazenil to produce a medicament for the treatment of cocaine dependency |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200100342 | 2001-02-15 | ||
| ESP200100342 | 2001-02-15 | ||
| PCT/ES2002/000061 WO2002064213A1 (en) | 2001-02-15 | 2002-02-08 | Use of flumazenil to produce a medicament for the treatment of cocaine dependency |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006200922A Division AU2006200922A1 (en) | 2001-02-15 | 2006-03-03 | Use of flumazenil to produce a medicament for the treatment of cocaine dependency |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002231811A1 true AU2002231811A1 (en) | 2003-02-20 |
| AU2002231811B2 AU2002231811B2 (en) | 2006-02-16 |
Family
ID=8496743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002231811A Ceased AU2002231811B2 (en) | 2001-02-15 | 2002-02-08 | Use of flumazenil to produce a medicament for the treatment of cocaine dependency |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7186711B2 (en) |
| EP (1) | EP1378267B1 (en) |
| JP (2) | JP4272885B2 (en) |
| KR (1) | KR100712571B1 (en) |
| CN (1) | CN1327843C (en) |
| AT (1) | ATE363923T1 (en) |
| AU (1) | AU2002231811B2 (en) |
| BR (1) | BR0207866A (en) |
| CA (1) | CA2436511C (en) |
| CY (1) | CY1106845T1 (en) |
| DE (1) | DE60220512T2 (en) |
| DK (1) | DK1378267T3 (en) |
| ES (1) | ES2287255T3 (en) |
| HK (1) | HK1061817A1 (en) |
| IL (1) | IL157144A0 (en) |
| MX (1) | MXPA03007281A (en) |
| NZ (1) | NZ528164A (en) |
| PT (1) | PT1378267E (en) |
| RU (1) | RU2322985C2 (en) |
| UA (1) | UA79586C2 (en) |
| WO (1) | WO2002064213A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050192271A1 (en) * | 2003-07-15 | 2005-09-01 | Hythiam, Inc. | Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse |
| DE60220512T2 (en) * | 2001-02-15 | 2008-02-07 | Hythiam, Inc., Los Angeles | USE OF FLUMAZENIL FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF COCAINE DEPENDENCE |
| WO2006110642A2 (en) | 2005-04-07 | 2006-10-19 | Hythiam, Inc. | Improved methods of and compositions for the prevention of anxiety, substance abuse, and dependence |
| US7855196B2 (en) | 2005-08-22 | 2010-12-21 | Pierre Mainville | Composition comprising a benzodiazepine agonist and a benzodiazepine antagonist |
| ES2289935B1 (en) * | 2006-07-14 | 2008-12-16 | Juan Jose Legarda Ibañez | EMPLOYMENT OF FLUMAZENILO IN THE DEVELOPMENT OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DEPRESSIVE PATHOLOGY. |
| WO2009027564A1 (en) * | 2007-08-08 | 2009-03-05 | Legarda Ibanez Juan Jose | Use and methods of use for an antagonist of the serotin3 receptor (5-ht3) and a selective modulator of chloride channels for the treatment of addiction to or dependence on medicines/drugs or nervous system disorders |
| US9396280B2 (en) * | 2008-06-23 | 2016-07-19 | Microsoft Technology Licensing, Llc | Command driven web site browsing |
| CA2827336C (en) | 2011-02-23 | 2016-01-26 | Coeruleus Ltd. | Flumazenil complexes, compositions comprising same and uses thereof |
| US9308616B2 (en) | 2013-01-21 | 2016-04-12 | Innovative Finishes LLC | Refurbished component, electronic device including the same, and method of refurbishing a component of an electronic device |
| EP3057596A4 (en) * | 2013-10-14 | 2017-03-29 | Palmaya Pty Ltd | Compositions and methods of administering same |
| CN107115359A (en) * | 2016-02-24 | 2017-09-01 | 郑恩哲 | Block drop prescription and its application in heroin or morphine drugs poisoning path |
| EP3661500A1 (en) | 2017-07-31 | 2020-06-10 | Novartis AG | Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028611A (en) * | 1989-06-29 | 1991-07-02 | The Regents Of The University Of Minnesota | Treatment for cocaine use |
| US5229120A (en) * | 1992-02-05 | 1993-07-20 | Devincent James F | Treatment for cocaine abuse |
| GB9420010D0 (en) | 1994-10-01 | 1994-11-16 | Marck Sharp & Dohme Limited | Nucleic acids |
| EP1133299A1 (en) * | 1998-11-23 | 2001-09-19 | Sepracor Inc. | 2-hydroxymethylolanzapine compositions and methods |
| EP1125579A3 (en) * | 2000-01-18 | 2003-01-02 | Pfizer Products Inc. | Uses of agrp-melanocortin receptor binding modulating compounds |
| DE60220512T2 (en) | 2001-02-15 | 2008-02-07 | Hythiam, Inc., Los Angeles | USE OF FLUMAZENIL FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF COCAINE DEPENDENCE |
| US6740677B2 (en) | 2002-08-19 | 2004-05-25 | Hong Xue | Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2′ hydroxyflavonoids |
-
2002
- 2002-02-08 DE DE60220512T patent/DE60220512T2/en not_active Expired - Lifetime
- 2002-02-08 IL IL15714402A patent/IL157144A0/en unknown
- 2002-02-08 RU RU2003127718/15A patent/RU2322985C2/en not_active IP Right Cessation
- 2002-02-08 CN CNB028049411A patent/CN1327843C/en not_active Expired - Fee Related
- 2002-02-08 MX MXPA03007281A patent/MXPA03007281A/en active IP Right Grant
- 2002-02-08 AT AT02711879T patent/ATE363923T1/en active
- 2002-02-08 CA CA002436511A patent/CA2436511C/en not_active Expired - Fee Related
- 2002-02-08 NZ NZ528164A patent/NZ528164A/en unknown
- 2002-02-08 WO PCT/ES2002/000061 patent/WO2002064213A1/en active IP Right Grant
- 2002-02-08 KR KR1020037010718A patent/KR100712571B1/en not_active IP Right Cessation
- 2002-02-08 AU AU2002231811A patent/AU2002231811B2/en not_active Ceased
- 2002-02-08 BR BR0207866-0A patent/BR0207866A/en not_active Application Discontinuation
- 2002-02-08 JP JP2002564005A patent/JP4272885B2/en not_active Expired - Lifetime
- 2002-02-08 EP EP02711879A patent/EP1378267B1/en not_active Expired - Lifetime
- 2002-02-08 DK DK02711879T patent/DK1378267T3/en active
- 2002-02-08 PT PT02711879T patent/PT1378267E/en unknown
- 2002-02-08 ES ES02711879T patent/ES2287255T3/en not_active Expired - Lifetime
- 2002-08-02 UA UA2003098460A patent/UA79586C2/en unknown
-
2003
- 2003-07-15 US US10/622,068 patent/US7186711B2/en active Active
-
2004
- 2004-07-03 HK HK04104788A patent/HK1061817A1/en not_active IP Right Cessation
-
2006
- 2006-12-22 US US11/615,460 patent/US20070142364A1/en not_active Abandoned
-
2007
- 2007-09-05 CY CY20071101148T patent/CY1106845T1/en unknown
-
2008
- 2008-04-30 JP JP2008117980A patent/JP2008201799A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
| HK1080361A1 (en) | The use of compound in the preparation of medicaments for treating demyelinating diseases | |
| AU2003300791A1 (en) | Combination therapy for the treatment of pain | |
| HK1116339A1 (en) | Methods of administering epothilone analogs for the treatment of cancer | |
| AU2002303502A1 (en) | Improved leads for the treatment of patients with chf | |
| AU2003217275A1 (en) | Azabicyclic compounds for the treatment of disease | |
| AU2002227958A1 (en) | Use of moulding compounds for producing treatment devices | |
| AU5618501A (en) | Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis | |
| AU2002210385A1 (en) | Furazanyl-triazole derivates for the treatment of diseases | |
| AU2002231811A1 (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
| AU2002226427A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
| GB0004531D0 (en) | The treatment of respiratory diseases | |
| AU2002322481A1 (en) | Use of r-nsaid compounds for anti-hiv treatment | |
| AU2001293891A1 (en) | New combination for the treatment of asthma | |
| AU2003251875A1 (en) | Combination therapy for the treatment of neoplasms | |
| PL375564A1 (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma | |
| AU2003289652A1 (en) | The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion | |
| HRP20030677A2 (en) | Methods of administering epothilone analogs for the treatment of cancer | |
| IL162509A (en) | Use of deoxypeganine for the production of a drug for treating clinical depression | |
| AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
| AU2003296545A1 (en) | Use of a trpm8-activating substance for the treatment of tumours | |
| AU7402201A (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
| AU2003269257A1 (en) | Use of cap-1 for the therapy of asthma | |
| AU2002361190A1 (en) | Preparation for the topical anaesthesia of the skin | |
| AU3071899A (en) | Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma |